Efficiency and Usability of the Iontophoretic Patch Feeligreen Diclofenac in Treating Acute Osteoarthritic Knee Pain

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02784691

Enrollment

Registered

2016-05-27

Start date

2016-10-31

Completion date

2017-07-31

Last updated

2024-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

The aim of the study is to evaluate the antalgic efficacity of Feeligreen® patch on osteoarthritic knee pain acute. This patch work by diffusion controlled by iontophoresis allowing an improvement of transdermal diffusion of active (Diclofenac).

Interventions

DEVICEFeeligreen patch

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

70 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with age above 70 years, * Having a knee Arthritis (unilateral or bilateral) for at least 6 months, * Pain intensity ≥ 40 mm on a visual analog scale (VAS) * Lack of analgesic treatment or analgesic,

Exclusion criteria

* Cognitive disorders : moderate to severe stage or not allowing an understanding of the VAS (as determined by the clinician) * A history of chronic inflammatory rheumatic disease, * Diagnosis of osteoarthritis of secondary origin, * Non-steroidal anti-inflammatory medication within 7 days prior to inclusion, * Diagnosis of severe hepatic and renal insufficiency, gastrointestinal bleeding, severe heart failure, * Allergy to diclofenac or similar activity substances such as other NSAIDs, aspirin, excipients, * Damaged skin

Design outcomes

Primary

Measure	Time frame	Description
Intensity reduction of pain	2 days	Measured by Visual Analog Scale

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026